Zhejiang Jing Pharmaceutical: Controlling shareholder and shareholders intend to reduce their holdings by no more than 1.04% of shares

NightAirdropper · 2026-02-14T10:29:34+00:00

Zhejiang Jingyao Pharmaceuticals announced that the controlling shareholder Sheng Zelin and shareholder Ningbo Zeao plan to reduce their holdings due to funding needs, with total reductions of 273,907 shares and 2,475,090 shares respectively. The reduction period is from March 17, 2026, to June 16, 2026, and the method of reduction will be through centralized bidding or block trades.

NightAirdropper

2026-02-14 10:29:34

Abstract generation in progress

Gelonghui February 13 — Zai Lab announced that its controlling shareholder, one of its actual controllers, and Chairman ZELINSHENG (Sheng Zelin), along with shareholder Ningbo Zeao, plan to reduce their holdings due to their own funding needs. ZELINSHENG (Sheng Zelin) intends to reduce no more than 273,907 shares, representing no more than 0.1035% of the total share capital; Ningbo Zeao plans to reduce no more than 2,475,090 shares, representing no more than 0.9350% of the total share capital. The reduction period is from March 17, 2026, to June 16, 2026, and the reduction will be conducted through centralized bidding or block trades. This reduction plan carries uncertainties and will not affect the company’s governance structure or ongoing operations.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.